Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
93.69
+2.23 (2.44%)
At close: Aug 29, 2025, 4:00 PM
94.58
+0.89 (0.95%)
After-hours: Aug 29, 2025, 7:00 PM EDT
Inspire Medical Systems Employees
Inspire Medical Systems had 1,246 employees as of December 31, 2024. The number of employees increased by 235 or 23.24% compared to the previous year.
Employees
1,246
Change (1Y)
235
Growth (1Y)
23.24%
Revenue / Employee
$691,262
Profits / Employee
$42,633
Market Cap
2.77B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,246 | 235 | 23.24% |
Dec 31, 2023 | 1,011 | 256 | 33.91% |
Dec 31, 2022 | 755 | 270 | 55.67% |
Dec 31, 2021 | 485 | 144 | 42.23% |
Dec 31, 2020 | 341 | 102 | 42.68% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
INSP News
- 6 days ago - Inspire Medical Systems, Inc. Announces Departure of Chief Financial Officer - GlobeNewsWire
- 9 days ago - Inspire Medical: Hiccups For The Sleep Business - Seeking Alpha
- 12 days ago - Inspire Medical Systems, Inc. to Present at the Wells Fargo 2025 Healthcare Conference - GlobeNewsWire
- 16 days ago - ALGN Investors Have Opportunity to Join Align Technology, Inc. Fraud Investigation with the Schall Law Firm - Business Wire
- 20 days ago - INSP Investors Have Opportunity to Join Inspire Medical Systems, Inc. Fraud Investigation with the Schall Law Firm - PRNewsWire
- 21 days ago - Inspire Medical Systems, Inc. Board Authorizes Share Repurchase Program - GlobeNewsWire
- 21 days ago - Baron Discovery Fund Q2 2025: Winners And Setbacks Shaping The Portfolio - Seeking Alpha
- 25 days ago - Inspire Medical Stock Strays Off Course Amid Structural Setback - Benzinga